Inogen Inc (INGN)
NASDAQ: INGNHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
INGN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $137.81M
- EPS (TTM)
- -$1.21
- Dividend yield
- None
- 52-week range
- 5.05 – 7.67
- Day range
- 5.24 – 5.68
- Volume / Avg
- 351.93K / 315.66K
- Beta
- —
- Shares outstanding
- 26.00M
52-week range
INGN stock today
On Nov 20, INGN ended the session at $5.30, shedding $0.12 (2.21%), versus the S&P 500's 3.70% decline. At this level, INGN sits near the bottom of its 52-week range of $5.05 to $7.67: 30.9% below the high, set on Apr 28, 2026 and 5.1% above the low. INGN is down 21.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 23.0%.
Inogen has posted a net loss over the last twelve months (EPS of -$1.21), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Inogen
Company profileInogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Andrew P. Reding
- Headquarters
- Beverly, MA
- Employees
- 753
- IPO year
- 2014
- Website
- provider.inogen.com
Financial highlights
Full financialsIn fiscal 2025, Inogen generated $348.7 million in revenue, up 3.9% from fiscal 2024, its 2nd consecutive year of revenue growth. Inogen reported a net loss of $22.7 million, compared with a loss of $35.9 million a year earlier. Gross margin was 44.2% (down from 46.1%) and operating margin -8.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $348.67M | $335.70M | $315.66M | $377.24M | $358.00M |
| Growth | +3.86% | +6.35% | -16.32% | +5.37% | +16.05% |
| Net income | $-22.75M | $-35.89M | $-102.45M | $-83.77M | $-6.33M |
| EPS (diluted) | $-0.86 | $-1.52 | $-4.42 | $-3.67 | $-0.28 |
Analyst forecast
ForecastConsensus (2 analysts)
strong_buy
Avg. price target
$10.75+102.83%
- Strong buy 1
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $-0.20 vs —
INGN news
All INGN news- Inogen, Inc. Enters Separation Agreement with Kevin R.M. Smith and Reduces Board SizeNasdaq
- Inogen (INGN) Q3 2026 Earnings Call TranscriptNasdaq
- Inogen Announces Third Quarter 2026 Financial ResultsBusiness Wire
- Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026Business Wire
- Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?NasdaqIDXX, DXCM, INGN
- Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure PersistsNasdaqINGN, RMD, INSP
- Should Investors Buy Inogen as Low Valuation Meets Execution Risk?NasdaqINGN, PHG, RMD
Inogen peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BOOMDMC Global Inc. | 6.70 | -6.94% | $137.62M | vs INGN |
| AMROAmaero Inc. | 5.80 | +3.57% | $160.76M | vs INGN |
| HDSNHudson Technologies Inc. | 3.91 | -4.17% | $164.57M | vs INGN |
| VIRCVirco Manufacturing Corporation | 5.91 | -1.17% | $93.16M | vs INGN |
| LAKELakeland Industries Inc. | 8.29 | -0.48% | $82.33M | vs INGN |
| AGPUAxe Compute Inc. | 5.71 | -10.85% | $77.94M | vs INGN |
| NTICNorthern Technologies International Corporation | 7.38 | -1.99% | $71.09M | vs INGN |
| OFLXOmega Flex Inc. | 21.15 | -2.08% | $213.49M | vs INGN |
Indexes, lists and sector
Inogen stock FAQ
What is Inogen's stock price today?
INGN last traded at $5.30 as of Nov 20, 4:00 PM EST, down 2.21% on the day. Prices are delayed at least 15 minutes.
Who is Inogen's CEO?
Mr. Andrew P. Reding is the chief executive officer of Inogen Inc, which has about 753 employees.
What is the INGN 52-week high?
The 52-week high for INGN is $7.67 and the 52-week low is $5.05. The stock is currently 30.9% below its high.